PLSE — Pulse Biosciences Share News
0.000.00%
Last trade - 00:00- $3.25bn
- $3.15bn
- $0.35m
Brief: Pulse Biosciences Announces Plans To Initiate A Rights Offering
Brief: Pulse Biosciences Q4 EPS USD -0.22
Brief: Pulse Biosciences First-In-Human Procedures With Its Novel Cellfx™ Nanosecond Pulsed Field Ablation (Nspfa™) Cardiac Catheter
Pulse Biosciences rises as FDA greenlights co's study on cardiac device
Brief: Pulse Biosciences Provides Updates With Respect To Proprietary CellFX nsPFA Cardiac Catheter And Cardiac Clamp
Pulse Biosciences rises after submitting marketing application for medical device
Brief: Pulse Biosciences Files 510(k) Submission with U.S. FDA for its CellFX nsPFA Percutaneous Electrode
Brief: Pulse Biosciences Q3 EPS USD -0.19
Brief: Pulse Biosciences Announces Collaboration With Cardionxt For NSPFA First-In-Human Atrial Fibrillation Study
Brief: Pulse Biosciences Inc Says May Offer Or Sell Up To 10.02 Million Shares Of Common Stock
Pulse Biosciences Inc reports results for the quarter ended in June - Earnings Summary
Brief: Pulse Biosciences, Inc. Q2 EPS USD -0.22
Pulse Biosciences Inc expected to post a loss of 22 cents a share - Earnings Preview
Brief: Pulse Biosciences Reports Business Updates And First Quarter 2023 Financial Results
Pulse Biosciences Inc expected to post a loss of 22 cents a share - Earnings Preview
Brief: Pulse Biosciences Announces $65 Million Private Placement
Brief: Pulse Biosciences Inc Reports Quarterly Loss Per Share Of $0.25 - Filing
Pulse Biosciences Inc reports results for the quarter ended in December - Earnings Summary
Brief: Pulse Biosciences Reports Fourth Quarter & Full Year 2022 Financial Results